Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Current nucleic acid amplification methods to detect Mycobacterium tuberculosis are complex, labor-intensive, and technically challenging. We developed and performed the first analysis of the Cepheid Gene Xpert System's MTB/RIF assay, an integrated hands-free sputum-processing and real-time PCR system with rapid on-demand, near-patient technology, to simultaneously detect M. tuberculosis and rifampin resistance. Analytic tests of M. tuberculosis DNA demonstrated a limit of detection (LOD) of 4.5 genomes per reaction. Studies using sputum spiked with known numbers of M. tuberculosis CFU predicted a clinical LOD of 131 CFU/ml. Killing studies showed that the assay's buffer decreased M. tuberculosis viability by at least 8 logs, substantially reducing biohazards. Tests of 23 different commonly occurring rifampin resistance mutations demonstrated that all 23 (100%) would be identified as rifampin resistant. An analysis of 20 nontuberculosis mycobacteria species confirmed high assay specificity. A small clinical validation study of 107 clinical sputum samples from suspected tuberculosis cases in Vietnam detected 29/29 (100%) smear-positive culture-positive cases and 33/39 (84.6%) or 38/53 (71.7%) smear-negative culture-positive cases, as determined by growth on solid medium or on both solid and liquid media, respectively. M. tuberculosis was not detected in 25/25 (100%) of the culture-negative samples. A study of 64 smear-positive culture-positive sputa from retreatment tuberculosis cases in Uganda detected 63/64 (98.4%) culture-positive cases and 9/9 (100%) cases of rifampin resistance. Rifampin resistance was excluded in 54/55 (98.2%) susceptible cases. Specificity rose to 100% after correcting for a conventional susceptibility test error. In conclusion, this highly sensitive and simple-to-use system can detect M. tuberculosis directly from sputum in less than 2 h.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have shown that Xpert does not cross‐react with other mycobacterial species (Blakemore 2010; Helb 2010).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Helb 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This represents a substantial reduction in diagnostic delay, thereby permitting real-time decision making and planning of treatment (5).”
From Xpert MTB/RIF for Rapid Diagnosis of Tuberculous Lymphadenitis from Fine-Needle-Aspiration Biopsy Specimens (2011) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies reported 98–100% agreement in detection of rifampicin resistance strains using the Xpert test and phenotypic drug susceptibility test [13,14,18,26].”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Such cases (Xpert-positive but culture-negative) are likely to be true TB positives as corroborated by the high specificity [14,18] and by the fact that the procedure is less prone to contamination due to the closed reaction chamber (real-time PCR technology) of Xpert.”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“In agreement with other studies [9,18,22], Xpert has a higher sensitivity than smear microscopy.”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Two-sided confidence intervals for the single proportion: comparison of seven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · Cited by 5,107
Probable Inference, the Law of Succession, and Statistical Inference
Wilson, E. B. (1927) · Journal of the American Statistical Association · doi:10.1080/01621459.1927.10502953 · Cited by 4,476
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
The association for the advancement of medical instrumentation
(1974) · Ultrasound in Medicine & Biology · doi:10.1016/0301-5629(74)90035-0 · Cited by 1,031
Anti-tuberculosis drug resistance in the world
Wilkinson, D. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90766-0 · Cited by 700
Molecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525 · cited 1×
“tuberculosis detection (15), this assay was too complex and too prone to operator errors, sample cross-contamination, and biohazards for rapid near-patient use.”
BackgroundEspinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507 · cited 3×
“Truly rapid results for drug susceptibility tests are particularly important in the management of drug-resistant tuberculosis (13).”
BackgroundMicroscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB
Moore, D. A. J., Evans, C. A. W., Gilman, R. H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Piñedo, Y., Saravia, J. C., Salazar, C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055524 · Cited by 468
Cited by
Items 601–700 of 940
Malhotra, A. G., Lokhande, L., Pakhare, A. P., Soni, P., Vishwakarma, S. P., Maurya, A. K., Singh, J., & Singh, S. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05177-7 · Cited by 6
“Xpert Ultra employed a similar principle with enhanced sensitivity, particularly for paucibacillary specimens, and included a “trace” call to identify very low bacterial loads [ 7].”
Žmak, L., Obrovac, M., & Janković, V. K. (2013) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2013.855322 · Cited by 6
Gupta, P. P. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i5.100 · Cited by 6
Guernier, V., Diefenbach-Elstob, T. R., Pelowa, D., Pollard, S., Burgess, G. W., McBryde, E. S., & Warner, J. M. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.12.004 · Cited by 6
“Because they are rapid and highly sensitive, molecular techniques have significantly improved the diagnosis of TB, especially in patients with paucibacillary infection (Cheng et al., 2004; Helb et al., 2010).”
BackgroundEvolutionary Development of Molecular Tools in the Diagnosis of Mycobacterium tuberculosis: A Review
Shrivastav, R., Punde, R. P., Pandey, H., Samarth, R. M., & Maudar, K. K. (2010) · Journal of Medical Sciences(Faisalabad) · doi:10.3923/jms.2010.124.129 · Cited by 6
Kumar, V. S., Dalton, T. L., Armstrong, L., Whitesell, A. N., Li, R., & Starks, A. M. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab528 · Cited by 6
Kaboré, O. D., Millogo, A., Sanogo, B., Birba, É., Poda, A., Nacro, B., Marcy, O., Godreuil, S., & Ouédraogo, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288671 · Cited by 6
Vocat, A., Luraschi, A., Antoni, C., Cathomen, G., Cichocka, D., Greub, G., Riabova, O., Makarov, V., Opota, O., Mendoza-Losana, A., et al. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01318-24 · Cited by 6
Walusimbi, S., Bwanga, F., Costa, A. D., Haile, M., Hoffner, S. E., & Joloba, M. L. (2013) · International Journal of Mycobacteriology · doi:10.1016/j.ijmyco.2013.06.001 · Cited by 6
Screening for tuberculosis in pregnancy
Bothamley, G. H. (2012) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.12.35 · Cited by 6
Chakraborty, S., Chakraborty, A., Talukder, T., Mukherjee, M., & Chatterjee, T. (2016) · Journal of Tuberculosis Research · doi:10.4236/jtr.2016.42008 · Cited by 6
“The GeneXpert MTB/RIF assay is a novel integrated diagnostic device that performs sample processing and hemi-nested real-time Polymerase Chain Reaction (PCR) analysis in a single hands-free step for the diagnosis of MTBC and rapid detection of Rifampicin (RIF) resistance in clinical specimens as well as in culture iso…”
BackgroundMethodHao, X., Bai, J., Ding, Y., Wang, J., Liu, Y., Yao, L., & Pan, W. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-5476 · Cited by 6
“Therefore, early, rapid, and accurate diagnosis of tuberculosis is of great significance for the control of a tuberculosis epidemic (12,13).”
BackgroundA global proficiency testing programme for Xpert® MTB/RIF using dried tube specimens, 2013–2015
Klein, K., DeGruy, K., Rey, Z., Hall, P., Kim, A., Gutreuter, S., & Alexander, H. L. (2020) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v9i1.1167 · Cited by 6
Guan, M. J., Zhang, J., Jia, Y., Teng, Y., Cao, X., & Li, Y. (2021) · PubMed · Cited by 6
Transrenal DNA Detection of Mycobacterium tuberculosis in Patients with Pulmonary Tuberculosis
Kim, T. Y., Kim, J., Kim, T., Oak, C., & Ryoo, S. (2023) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_12_23 · Cited by 6
Yadav, P., Mahour, P., Agarwal, A., & Garg, A. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_277_23 · Cited by 6
Rapid and Biosecure Diagnostic Test for Tuberculosis
Garberi, J. E., Labrador, J., Garberi, F., Garberi, J. E., Peneipil, J., Garberi, M., Scigliano, L., & Troncoso, A. (2012) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9413-7 · Cited by 6
Real-Time Polymerase Chain Reaction: Applications in Diagnostic Microbiology
Saeed, K. B. A., & Ahmad, N. (2013) · International Journal of Medical Students · doi:10.5195/ijms.2013.22 · Cited by 6
EVALUATION OF CARTRIDGE BASED NUCLEIC ACID AMPLIFICATION TEST IN DIAGNOSIS OF PULMONARY TUBERCULOSIS
Mukherjee, S., Biswas, D., Begum, S., Ghosh, P., Paul, A., & Sarkar, S. (2017) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2017/1147 · Cited by 6
The impact of repeated NALC/NaOH- decontamination on the performance of Xpert MTB/RIF assay
Rachow, A., Saathoff, E., Mtafya, B., Mapamba, D. A., Mangu, C., Rojas-Ponce, G., Ntinginya, N. E., Boeree, M. J., Heinrich, N., Gillespie, S. H., et al. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.04.001 · Cited by 6
Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization
Wood, H. N., Venken, T., Willems, H., Jacobs, A., Reis, A. J., da Silva, P. E. A., Homolka, S., Niemann, S., Rohde, K. H., & Hooyberghs, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212064 · Cited by 7
Gliddon, H. D., Shorten, R. J., Hayward, A. C., & Story, A. (2019) · ERJ Open Research · doi:10.1183/23120541.00165-2018 · Cited by 6
Tang, Y., Yu, J., Yang, G., Li, L., Cheng, J., Wang, H., Liu, G., Pan, Z., Yu, X., & Li, W. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115243 · Cited by 6
Mycobacterial Infections in Monkeys
Mendoza, A. P., Mitman, S. L., & Rosenbaum, M. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-52283-4_4 · Cited by 6
Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study
Bahraminia, F., Zangiabadian, M., Nasiri, M. J., Fattahi, M., Goudarzi, M., Ranjbar, R., & Fooladi, A. A. I. (2021) · New Microbes and New Infections · doi:10.1016/j.nmni.2021.100909 · Cited by 6
Principles of Anti-infective Therapy
Eliopoulos, G. M., & Moellering, R. C. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00017-5 · Cited by 10
Roy, R. D., & Gupta, S. D. (2022) · Indian Journal of Respiratory Care · doi:10.4103/ijrc.ijrc_123_21 · Cited by 6
Haraka, F., Rutaihwa, L. K., Battegay, M., & Reither, K. (2012) · BMJ Case Reports · doi:10.1136/bcr.01.2012.5713 · Cited by 6
Armstrong, D. T., Tacheny, E. A., Olinger, G. G., Howard, R., Lemmon, M. M., Dasgupta, D., Eisemann, E., & Parrish, N. M. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00778-21 · Cited by 6
Treffon, J., Isserstedt-John, N., Klemm, R., Gärtner, C., & Mellmann, A. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00862-24 · Cited by 5
Zhang, S., Xu, Y., Huang, M., Pan, Y., Shangguan, J., Peng, R., Hu, X., Zheng, F., Luo, N., Chen, X., et al. (2025) · Thorax · doi:10.1136/thorax-2025-223553 · Cited by 5
“Molecular testing, mainly real-time PCR assays originally designed to detect genomic DNA (gDNA) separated from intact MTB bacilli, 12 has shown improved sensitivity when applied to pleural fluid.”
Das, P., Ganguly, S. B., & Mandal, B. (2019) · Biomedical and Biotechnology Research Journal (BBRJ) · doi:10.4103/bbrj.bbrj_56_19 · Cited by 5
“0001 shows higher detection[12] of MTB through CBNAAT in smear-positive cases than negative cases; however, the analytical sensitivity of CBNAAT and smear microscopy is 100 colony-forming unit (CFU)/ml[13] and 5000–10,000 CFU/ml,[14] respectively.”
BackgroundBiosensor and its implementation in diagnosis of infectious diseases
Sahoo, S., Sahu, S. N., Pattanayak, S. K., Misra, N., & Suar, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820781-9.00002-4 · Cited by 5
Xpert MTB/RIF to diagnose tuberculosis in children
Theron, G. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00111-3 · Cited by 5
Zimenkov, D. V., Kulagina, E. V., Antonova, O. V., Суржиков, С. А., Bespyatykh, J., Shitikov, E. A., Ilina, E. N., Mikhailovich, V. M., Заседателев, А. С., & Gryadunov, D. A. (2014) · Molecular Biology · doi:10.1134/s0026893314020186 · Cited by 5
Clinical utility of tissue polymerase chain reaction in the diagnosis of spinal tuberculosis
Monni, T., Visser, A. T., Visser, H., & Motsitsi, S. (2012) · UpSpace Institutional Repository (University of Pretoria) · Cited by 5
Nucleic Acid Amplification Methods Overview
(2016) · Molecular Microbiology · doi:10.1128/9781555819071.ch1 · Cited by 7
Rakha, E., & Hakeem, M. A. (2017) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2017.610.302 · Cited by 5
“When the tubes were flagged positive, ZN staining and culture on 5% sheep blood agar were performed from the tube directly to rule out any contamination as per the manufacturer’s instructions (Hosne et al., 2016).”
BackgroundMethodMaulina, N., Hayati, Z., Hasballah, K., Zulkarnain, Z., Waraztuty, I., & Defadheandra, A. (2024) · Journal of Research in Health Sciences · doi:10.34172/jrhs.2024.136 · Cited by 5
“The GeneXpert MTB/RIF (Cepheid Inc., USA) 13 and Genotype MTBDRplus (Hain Lifescience Inc., Germany) 14 have been endorsed by the WHO as rapid genotypic rifampicin susceptibility tests.”
Micaraseth, T., Shuangshoti, S., Chaiprabha, K., Wanpiyarat, N., Chantranuwatana, P., & Phanomchoeng, G. (2025) · IEEE Access · doi:10.1109/access.2025.3568073 · Cited by 5
“High costs are associated with these culture-based methods [10], [12] Machine learning technology, particularly deep learning (DL), plays a vital role in TB detection by analyzing large datasets efficiently.”
Kilfoil, K. M., Mayne, E. S., Scott, L. E., & Stevens, W. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134404 · Cited by 5
“The major advantage of using Xpert in the diagnosis of MTBC on fluid specimens, however, is that Xpert is able to produce a result despite the high rate of contamination of extrapulmonary fluid specimens [12].”
BackgroundTuberculosis: laboratory diagnosis and treatment strategies
McHugh, T. D. (2013) · CABI eBooks · doi:10.1079/9781845938079.0000 · Cited by 5
Hung, H., Chan, C., Tsao, S., Chen, S., Wu, T., Lu, M., Wu, D.-J., Huang, S.-J., & Lee, Y. (2012) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(12)70318-5 · Cited by 5
Liu, X., Bian, S., Zhang, Y., Zhang, L., Yang, Q., Wang, P., Xu, Y., Shi, X., Zhang, Y., & Chemaly, R. F. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-2084-z · Cited by 5
“We may apply the new method of GeneXpert MTB/RIF in the future which can detect MTB in 2 h with a good sensitivity and specificity [18].”
MethodBroda, A., Nikolayevskyy, V., Casali, N., Khan, H., Bowker, R., Blackwell, G., Patel, B., Hume, J., Hussain, W., & Drobniewski, F. A. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3246-2 · Cited by 5
“Results (i.e. TB, NTM, isoniazid and rifampicin resistance or sensitivity) were returned to ICL and performance was compared to reference diagnostic tests.”
InfluentialHan, Y., Xiao, N., Huang, S., Qin, M., Che, N., & Liu, Z. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201020666190716104131 · Cited by 5
Ibrahem, R., & El-Helbawy, R. (2020) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.4103/ejcdt.ejcdt_120_19 · Cited by 5
Quadir, N., Rahman, S. A., Ahmad, J., Das, A. K., Arora, N., Sheikh, J. A., Gupta, N. K., Kapur, P., Dudeja, M., Hasnain, S. E., et al. (2021) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.05.014 · Cited by 7
Guo, J., Liu, R., Shi, J. P., Huo, F., Shang, Y., Wang, F., Gao, M., & Li, S. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s313717 · Cited by 5
Benellam, Y. K. J., Özkan, Ö., & Aziz, Z. S. (2022) · Bionatura · doi:10.21931/rb/2022.07.02.50 · Cited by 5
“GeneXpert MTB / RIF is a nucleic acid test established by Xpert, Cepheid, Sunnyvale, CA, USA, developed to simultaneously diagnose TB and detect RIF resistance by detecting mutations in the RIF resistance determining region RRDR of the rpoB gene 2,12 .”
MethodMoon, H., Hur, M., Kim, J., & Yun, Y. (2014) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21742 · Cited by 5
Pang, Y., Lu, J. L., Yang, J., Wang, Y., Cohen, C., Ni, X., & Zhao, Y. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.03.011 · Cited by 5
“Nested PCR, a modification of conventional PCR, serves as an alternative for increasing the sensitivity in PCR, especially for detecting samples under the LOD of a specific PCR [16].”
MethodSeni, J., Kidenya, B. R., Anga, M., Kapesa, A., Meda, J., Mutakyawa, R., Mkomwa, Z., Marcel, F., Changalucha, J. M., & Mshana, S. E. (2015) · Healthcare in Low-resource Settings · doi:10.4081/hls.2015.5011 · Cited by 5
New developments in the laboratory diagnosis of tuberculosis : main article
Nicol, M. P. (2010) · CME/Continuing medical education · Cited by 7
Biomarkers and diagnostics for tuberculosis
Martin, A., Barrera, L., & Palomino, J. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62027-2 · Cited by 5
Weinrick, B. C. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01504-19 · Cited by 5
“tuberculosis and the rifampin resistance-determining region (RRDR) of its genome (5).”
BackgroundNaidoo, P., Dunbar, R., Caldwell, J., Lombard, C., & Beyers, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172143 · Cited by 4
Wang, M., Wu, Y., Xi, Y., Fan, L., Sun, F., Zhou, G., Wang, W., YanHong, Y., Sun, J., Xue, Y., et al. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107598 · Cited by 4
Ou, X., Song, Z., Xing, R., Zhao, B., Pei, S., Teng, C., Zhang, L., Sun, Q., Liu, F., Xia, H., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1439099 · Cited by 4
Chang, J., Sung, H., Jo, K.-W., Shim, T. S., & Kim, M.-N. (2021) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2020.978 · Cited by 4
Fan, D., Yue, Y., Li, H., Shang, X., Li, H. Z., Xiao, R., & Cai, L. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102349 · Cited by 4
USE OF THE RAPID MOLECULAR TEST FOR TUBERCULOSIS AMONG PEOPLE DEPRIVED OF LIBERTY: A SCOPING REVIEW
Naves, E. F., Andrade, R. L. D. P., de Faria, M. G. B. F., Magnabosco, G. T., Bonfim, R. O., Ferreira, M. R. L., Bóllela, V. R., & Monroe, A. A. (2024) · Texto & Contexto - Enfermagem · doi:10.1590/1980-265x-tce-2023-0288en · Cited by 4
“…by amplifying nucleic acids through the DNA Polymerase Chain Reaction (PCR) technique in a sample of sputum or other material within a period of up to two hours, as well as identifying strains resistant to rifampicin, one of the main first-line antibiotics used in the treatment of TB 14–15 .”
MethodPhanuphak, N., Varma, J. K., Kittikraisak, W., Teeratakulpisarn, N., Phasitlimakul, S., Suwanmala, P., Pankam, T., Burapat, T., Tasaneeyapan, T., McCarthy, K. D., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318258c675 · Cited by 4
“Median age, year (IQR) 32 (28-38) 32 (28-38) 32 (27-39) 0.”
Adikaram, C. P., Perera, J. A., & Wijesundera, S. S. (2013) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2013.11.006 · Cited by 4
“, 2011), XpertMycobacterium tuberculosis/ rifampicin assay (Helb et al., 2010) and line probe assays (LPA) such as the INNO-LiPARif.”
MethodLi, Q., Ou, X. C., Pang, Y., Xia, H., Hai, H., Zhao, B. T., Wang, S. F., & Zhao, Y. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.03.008 · Cited by 4
Luukinen, B. V., Vuento, R., & Hirvonen, J. J. (2019) · Apmis · doi:10.1111/apm.12947 · Cited by 4
“smear microscopy methods in analytic sensitivity (19, 20).”
MethodSix species of nontuberculous mycobacteria carry non-identical 16S rRNA gene copies
Takeda, K., Chikamatsu, K., Igarashi, Y., Morishige, Y., Murase, Y., Aono, A., Yamada, H., Takaki, A., & Mitarai, S. (2018) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2018.08.012 · Cited by 4
Diagnostics: The Role of the Laboratory
Afzal, A., Kaplan, H. M., Motazedi, T., Qureshi, T. M., & Woc-Colburn, L. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-33803-9_4 · Cited by 4
Kumar, R., Sood, A. K., Bajaj, M., & Kanga, A. (2019) · Pediatric Infectious Disease · doi:10.5005/jp-journals-10081-1229 · Cited by 4
Development of dried tube specimens for Xpert MTB/RIF proficiency testing
DeGruy, K., Klein, K., Rey, Z., Hall, P., Kim, A., & Alexander, H. L. (2020) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v9i1.1166 · Cited by 5
Katoch, C. D. S., Peter, D. K., Marwah, V., Kumar, K., & Bhati, G. (2021) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2021.04.007 · Cited by 5
Gargava, A., Raghuwanshi, S., Verma, P., & Jaiswal, S. (2021) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-021-02673-y · Cited by 4
Efectividad del tratamiento antituberculoso en 3 ciudades de Colombia
Machado‐Alba, J. E., Cantor, A. M., Montes, A., & Quintero, C. A. (2013) · Infectio · doi:10.1016/s0123-9392(13)70166-8 · Cited by 4
ROLE OF GENE-XPERT IN DIAGNOSIS OF SMEAR NEGATIVE PULMONARY TUBERCULOSIS
Kumar, R. D., Thakur, S., Abhishek, K., Anupam, C., Asish, K. S., & Shyama, K. (2015) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2015/2578 · Cited by 4
Rahman, H., Khan, S. U., Khan, M. A., Qasim, M., Jabbar, A., Noor, S., Khan, Z., Khan, T. A., Hussain, M., Muhammad, N., et al. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.02.013 · Cited by 4
Diagnosis of Childhood Tuberculosis
Shah, A. K., & Shah, A. A. (2019) · Pediatric Infectious Disease · doi:10.5005/jp-journals-10081-1103 · Cited by 4
Varona, M., Shimelis, O. I., & Anderson, J. L. (2020) · Analytical Methods · doi:10.1039/d0ay00980f · Cited by 4
David, A., Singh, L., Silva, P. D., Scott, L. E., & Stevens, W. S. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s247524 · Cited by 4
Song, Y.-H., Li, Q., Ma, L., Liu, R., Jiang, G., Li, Q., & Gao, M. (2020) · Journal of International Medical Research · doi:10.1177/0300060520921640 · Cited by 4
The impact of helminth infection in patients with active tuberculosis
Abate, E. (2013) · DiVA (Linkoping University) · Cited by 5
Addai, Y. N., Acquah, S. E. K., Ganu, H. M., Vicar, E. K., Zeyeh, D. E., Abdul-Karim, A., Walana, W., Attipoe, I. M., & Quaye, L. (2024) · Public Health Challenges · doi:10.1002/puh2.160 · Cited by 3
“The LiPA further complements the Xpert MTB/RIF screening assay by validating rifampicin susceptibility and providing information on isoniazid susceptibility [21].”
Gous, N. M., Isherwood, L. E., David, A., Stevens, W. S., & Scott, L. E. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03340-14 · Cited by 3
“This was due to the low bacillary load on the DCS designed for detection at a minimum of 150 CFU/ml, which is the lower limit of detection of the Xpert MTB/RIF test (9).”
BackgroundMethodMansoori, N., Pahlavanzadeh, B., & Arabmofrad, F. (2020) · Apmis · doi:10.1111/apm.13085 · Cited by 3
“limit of the Xpert assay in sputum samples is higher than the culture method (6).”
BackgroundMethodInfluentialBartels, J. G. E., Takenov, N., Chingissova, L., Rakisheva, A. S., Eleusizova, A., Bismilda, V., Yeraliyeva, L. T., & Amor, Y. B. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf342 · Cited by 3
“BD MAX also requires lower limits of detection for drug susceptibility testing [22] and has a higher daily through-put of tests [23] than Xpert MTB/RIF.”
Detection of Drug-Resistant Mycobacterium tuberculosis
Engström, A., & Juréen, P. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2715-9_24 · Cited by 3
Praveen, J. V., V., R. R. V., Kishan, S. H., Sowjanya, D., Prithvi, B. K., Ramya, G., V, B. P., V, & Rao, M. (2014) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2014/3118 · Cited by 3
Tuberculous meningitis in an immunocompetent male complicated by hydrocephalus
Dunphy, L., Shetty, P., Randhawa, R., Rani, K. A., & Duodu, Y. (2016) · BMJ Case Reports · doi:10.1136/bcr-2015-213916 · Cited by 3
Microbial sensor for drug susceptibility testing ofMycobacterium tuberculosis
Zhang, Z., Wang, D., Li, C.-Y., Deng, J., Zhang, J.-B., Bi, L., & Zhang, X. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13617 · Cited by 3
“The Word Health Organization (WHO) recently endorsed this method (Helb et al. 2010; Lawn et al. 2013).”
MethodEvaluasi MetodeGeneXpert MTB/RIF dengan SampelRaw Sputum untuk Mendeteksi Tuberkulosis Paru
Susilawati, T. N., Saptawati, L., Damayanti, K. E., & Larasati, R. (2019) · Jurnal Epidemiologi Kesehatan Indonesia · doi:10.7454/epidkes.v2i1.2074 · Cited by 3
Need for caution when interpreting Xpert® MTB/RIF results for rifampin resistance among children
Murithi, W. B., Click, E. S., McCarthy, K. D., Okeyo, E., Sitati, R., Anyango, I., Okumu, A., Mchembere, W., Song, R., & Cain, K. P. (2021) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.21.0126 · Cited by 4
Torane, V. P., Nataraj, G., Kanade, S. R., & Deshmukh, C. T. (2023) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2023.03.017 · Cited by 3
Clinical Features and Management of HIV/AIDS in Adults
Meintjes, G., Bekker, L., & Wood, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-7959-7.00015-4 · Cited by 3
Wazahat, R., Haider, M., Chattopadhya, D., & Dudeja, M. (2023) · Epidemiology and Health System Journal · doi:10.34172/ehsj.2023.19 · Cited by 3
Wu, G., Wang, J., Xu, X., Wei, H., Cai, L., & Liu, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31680 · Cited by 4
Wei, J., Qian, X.-Q., Wan, Y., Zhao, X., Zhang, C., Guo, W., & Zhu, Z. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09684-4 · Cited by 3
“Which is consistent with Danica Hleb’s study, the tuberculocidal effect of SR increases with the length of exposure [18].”
BackgroundResultHamed, A. H. G., Ahmed, M. M., Adawy, E. R. A. A., & Fathy, R. M. M. (2025) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.4103/ecdt.ecdt_55_24 · Cited by 3
Zou, Y., Wang, Z., Wei, Z., Bai, G., Wang, X., Qu, S., Zhong, G., & Gao, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1653602 · Cited by 3
“For NTM species, LODs ranged from 166.602 to 690.629 CFU/mL.”
InfluentialTechnical and Clinical Niches for Point of Care Molecular Devices
Baron, E. J., & Campbell, S. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3970-7_33 · Cited by 3
“If one or more of the regions fails to bind its speci fi c beacon, but at least two regions are present, the M. tuberculosis strain is reported as resistant [ 23 ] .”
BackgroundHella, J., Hiza, H. C., Mfinanga, E. H., & Reither, K. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-009156 · Cited by 3
Rzechorzek, W., Szańkowska, M., Szczepankiewicz, B., Cyran, A., & Safianowska, A. (2014) · Advances in respiratory medicine · doi:10.5603/piap.2014.0056 · Cited by 3
“Although initially we wanted to perform 40 reactions, the technology of cartridges in real-time 435www.pneumonologia.viamedica.pl PCR Xpert MTB/RIF (Cepheid, USA) has changed.”
BackgroundMethodInfluential
Metadata
- Authors
- Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., Safi, H., Blakemore, R., Lan, N. T. N., Jones-López, E. C., Levi, M., Burday, M., Ayakaka, I., Mugerwa, R. D., McMillan, B., Winn-Deen, E., Christel, L., Dailey, P., Perkins, M. D., Persing, D. H., & Alland, D.
- Affiliations
- Rutgers New Jersey Medical School (US)
- Cepheid (United States) (US)
- Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry, New Jersey, Newark, New Jersey
- FIND (CH)
- Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
- Montefiore Medical Center (US)
- Makerere University (UG)
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 48
- Issue
- 1
- Pages
- 229-237
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC2812290
- OpenAlex
- W2112022845
- Cited by
- 914
- References
- 59
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 35 · 2023: 33 · 2022: 36 · 2021: 45 · 2020: 65 · 2019: 55 · 2018: 61 · 2017: 62 · 2016: 63 · 2015: 62 · 2014: 74 · 2013: 71 · 2012: 62
- FWCI
- 41.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R41AI052523, R42AI052523, R42-AI52523, R41-AI52523)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- Mycobacterium tuberculosis detection, rifampicin resistance, Xpert MTB/RIF, point-of-care testing, real-time PCR, sputum, detection limit, nontuberculous mycobacteria, retreatment tuberculosis, tuberculosis diagnosis
- MeSH terms
- Adolescent, Adult, Aged, Antitubercular Agents, Bacteriological Techniques, Female, Humans, Male, Middle Aged, Mycobacterium tuberculosis, Rifampin, Sensitivity and Specificity, Sputum, Tuberculosis, Uganda, Vietnam, Polymerase Chain Reaction, Point-of-Care Systems, Drug Resistance, Bacterial, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.